Teva Recalls Mesalamine Tablets Due to Failed Dissolution Testing
Teva Pharmaceuticals is recalling 133,829 bottles of Mesalamine Delayed-Release Tablets because stability testing revealed out-of-specification dissolution results.
- Product
- MESALAMINE — MESALAMINE (MESALAMINE)
- Category
- Drug
- Distribution
- Distributed nationwide